GYRE THERAPEUTICS, INC. - GYRE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$32.21M
QoQ value delta ($000)
+$8.543M (+36.1%)
Implied price effect (QoQ)
-0.93%
Shares
Total shares
4,608,886
QoQ shares delta
+1,254,147 (+37.38%)
Total shares held by funds (by quarter)

Market chart (GYRE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 56 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 8,483 1,201,589 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 6,859 984,204 0.0%
BlackRock, Inc. 5,287 758,630 0.0%
GEODE CAPITAL MANAGEMENT, LLC 3,007 431,414 0.0%
STATE STREET CORP 1,507 216,326 0.0%
SBI Securities Co., Ltd. 1,190 170,837 0.03%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,151 165,238 0.0%
VANGUARD FIDUCIARY TRUST CO 959 137,682 0.0%
NORTHERN TRUST CORP 932 133,841 0.0%
GOLDMAN SACHS GROUP INC 509 73,122 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 486 69,814 0.0%
Bank of New York Mellon Corp 300 43,144 0.0%
DIMENSIONAL FUND ADVISORS LP 176 25,268 0.0%
ALLIANCEBERNSTEIN L.P. 154 21,830 0.0%
STRS OHIO 147 21,100 0.0%
UBS Group AG 146 21,087 0.0%
FMR LLC 130 18,717 0.0%
Brevan Howard Capital Management LP 96 13,808 0.0%
RHUMBLINE ADVISERS 91 13,116 0.0%
BANK OF AMERICA CORP /DE/ 73 10,538 0.0%
DEUTSCHE BANK AG\ 73 10,613 0.0%
Vanguard Global Advisers, LLC 69 9,983 0.0%
MORGAN STANLEY 60 8,641 0.0%
Tower Research Capital LLC (TRC) 40 5,763 0.0%
ROYAL BANK OF CANADA 39 5,605 0.0%